We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1901
Chatham Lodging
CLDT
$631M
| $187K | ﹤0.01% |
18,900
| – | – |
|
1902
Perdoceo Education
PRDO
$2.07B
| $187K | ﹤0.01% |
18,120
| – | – |
|
|
RNAM
1903
DELISTED
Avidity Biosciences
RNAM
| $187K | ﹤0.01% |
11,480
+660
| +6% | +$12.6K |
|
1904
Viper Energy
VNOM
$8.24B
| $185K | ﹤0.01% |
6,460
| – | – |
|
|
BTRS
1905
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $185K | ﹤0.01% |
+19,950
| New | +$129K |
|
1906
CareDx
CDNA
$1.86B
| $184K | ﹤0.01% |
10,810
| – | – |
|
1907
IMAX
IMAX
$2.52B
| $184K | ﹤0.01% |
13,060
| – | – |
|
1908
Jackson Financial
JXN
$8.57B
| $184K | ﹤0.01% |
+6,640
| New | +$196K |
|
1909
Amplitude
AMPL
$1.17B
| $183K | ﹤0.01% |
+11,800
| New | +$189K |
|
1910
Clearwater Paper
CLW
$292M
| $181K | ﹤0.01% |
4,820
| – | – |
|
1911
Digi International
DGII
$2.53B
| $181K | ﹤0.01% |
5,240
+1,540
| +42% | +$47.8K |
|
1912
Genworth Financial
GNW
$3.81B
| $181K | ﹤0.01% |
+51,770
| New | +$209K |
|
|
SRDX
1913
DELISTED
Surmodics
SRDX
| $181K | ﹤0.01% |
5,970
| – | – |
|
1914
Xometry
XMTR
$4.58B
| $181K | ﹤0.01% |
3,190
+1,520
| +91% | +$71K |
|
1915
Huron Consulting
HURN
$2.01B
| $180K | ﹤0.01% |
+2,720
| New | +$181K |
|
1916
Dime Commercial Bancshares
DCOM
$1.81B
| $179K | ﹤0.01% |
6,100
| – | – |
|
1917
Planet Labs
PL
$7.2B
| $179K | ﹤0.01% |
+32,930
| New | +$182K |
|
|
PLL
1918
DELISTED
Piedmont Lithium
PLL
| $179K | ﹤0.01% |
3,340
+2,150
| +181% | +$111K |
|
1919
BOK Financial
BOKF
$8.65B
| $178K | ﹤0.01% |
+2,000
| New | +$173K |
|
1920
Rivian
RIVN
$23.7B
| $177K | ﹤0.01% |
5,350
+1,850
| +53% | +$63.1K |
|
|
ENFN
1921
DELISTED
Enfusion, Inc.
ENFN
| $177K | ﹤0.01% |
14,330
+4,900
| +52% | +$59.8K |
|
1922
Driven Brands
DRVN
$2.46B
| $176K | ﹤0.01% |
6,300
+5,960
| +1,753% | +$184K |
|
1923
Marcus Corp
MCS
$761M
| $176K | ﹤0.01% |
12,700
| – | – |
|
1924
Scansource
SCSC
$1.16B
| $176K | ﹤0.01% |
6,652
| – | – |
|
|
INFN
1925
DELISTED
Infinera Corporation Common Stock
INFN
| $176K | ﹤0.01% |
+36,330
| New | +$199K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.